Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthRX vs NP2GO

HealthRX
Site position #36

Lower grade

vs+2.7
NP2GO
Site position #37

Higher grade

The verdict

NP2GO takes it — 80.2/100 to 77.5/100.

NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthRX +4
85
81
Dose & formulationNP2GO +16
64
80
Clinical oversightHealthRX +8
87
79
Labs & monitoringHealthRX +4
82
78
FulfillmentHealthRX +4
86
82
Contract termsNP2GO +39
43
82
HealthRX · left barNP2GO · right bar

The numbers

MetricHealthRXNP2GO
WeighScore77.5/10080.2/100
GradeC+B−
Site position#36#37
Semaglutide$149 first month, then $165/month; $1,163 per 12-month subscription$150/mo
Tirzepatide$193 first month, then $214/month; $2,123 per 12-month subscription$250/mo
CoverageNot publicly listed40 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
HealthRX

Site position #36 · C+

Strengths

  • Product pages publish due-today and next-charge tables
  • Medication if approved, provider review and overnight shipping are included
  • Longer plans offer a one-time purchase option without automatic renewal

Where it loses points

  • Annual headline rates require payment for 12 months upfront
  • Monthly subscription prices rise after the first payment
  • Product navigation still shows older starting prices
  • Injection supplies are not confirmed as standard inclusions
NP2GO

Site position #37 · B−

Strengths

  • Both molecules
  • 40-state footprint
  • Transparent listed pricing

Where it loses points

  • Independent LegitScript certification has not been verified for this review
  • Upper-mid pricing ($150/$250)
  • Not all 50 states

Featured provider

HealthRX

HealthRX scores 77.5/100 (C+). HealthRX’s current injection plans disclose the first charge and renewal separately. The lowest monthly equivalents require a prepaid year; a monthly subscription offers a smaller initial commitment.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard